Gilead Sciences, Inc. - stock earnings
GILD Upcoming estimated earnings
Date | Low Revenue | Average Revenue | High Revenue |
---|---|---|---|
April 25, 2024 BeforeMarket | 6.0 billion | 6.4 billion | 6.8 billion |
GILD Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 1.4 billion USD | 7.1 billion USD |
2023Q3 | 2.2 billion USD | 7.1 billion USD |
2023Q2 | 1.0 billion USD | 6.6 billion USD |
2023Q1 | 1.0 billion USD | 6.4 billion USD |
2022Q4 | 1.6 billion USD | 7.4 billion USD |
2022Q3 | 1.8 billion USD | 7.0 billion USD |
2022Q2 | 1.1 billion USD | 6.3 billion USD |
2022Q1 | 12.0 million USD | 6.6 billion USD |
2021Q4 | 382.0 million USD | 7.2 billion USD |
2021Q3 | 2.6 billion USD | 7.4 billion USD |
2021Q2 | 1.5 billion USD | 6.2 billion USD |
2021Q1 | 1.7 billion USD | 6.4 billion USD |
2020Q4 | 1.6 billion USD | 7.4 billion USD |
2020Q3 | 360.0 million USD | 6.6 billion USD |
2020Q2 | -3.3 billion USD | 5.1 billion USD |
2020Q1 | 1.6 billion USD | 5.5 billion USD |
2019Q4 | 2.7 billion USD | 5.9 billion USD |
2019Q3 | -1.2 billion USD | 5.6 billion USD |
2019Q2 | 1.9 billion USD | 5.7 billion USD |
2019Q1 | 2.0 billion USD | 5.3 billion USD |
2018Q4 | 3.0 million USD | 5.8 billion USD |
2018Q3 | 2.1 billion USD | 5.6 billion USD |
2018Q2 | 1.8 billion USD | 5.6 billion USD |
2018Q1 | 1.5 billion USD | 5.1 billion USD |
2017Q4 | -3.9 billion USD | 5.9 billion USD |
2017Q3 | 2.7 billion USD | 6.5 billion USD |
2017Q2 | 3.1 billion USD | 7.1 billion USD |
2017Q1 | 2.7 billion USD | 6.5 billion USD |
2016Q4 | 3.1 billion USD | 7.3 billion USD |
2016Q3 | 3.3 billion USD | 7.5 billion USD |
2016Q2 | 3.5 billion USD | 7.8 billion USD |
2016Q1 | 3.6 billion USD | 7.8 billion USD |
2015Q4 | 4.7 billion USD | 8.5 billion USD |
2015Q3 | 4.6 billion USD | 8.3 billion USD |
2015Q2 | 4.5 billion USD | 8.2 billion USD |
2015Q1 | 4.3 billion USD | 7.6 billion USD |
2014Q4 | 3.5 billion USD | 7.3 billion USD |
2014Q3 | 2.7 billion USD | 6.0 billion USD |
2014Q2 | 3.7 billion USD | 6.5 billion USD |
2014Q1 | 2.2 billion USD | 5.0 billion USD |
2013Q4 | 791.4 million USD | 3.1 billion USD |
2013Q3 | 788.6 million USD | 2.8 billion USD |
2013Q2 | 772.6 million USD | 2.8 billion USD |
2013Q1 | 722.2 million USD | 2.5 billion USD |
2012Q4 | 762.5 million USD | 2.6 billion USD |
2012Q3 | 675.5 million USD | 2.4 billion USD |
2012Q2 | 711.6 million USD | 2.4 billion USD |
2012Q1 | 442.0 million USD | 2.3 billion USD |
2011Q4 | 665.1 million USD | 2.2 billion USD |
2011Q3 | 741.1 million USD | 2.1 billion USD |
2011Q2 | 746.2 million USD | 2.1 billion USD |
2011Q1 | 651.1 million USD | 1.9 billion USD |
2010Q4 | 629.4 million USD | 2.0 billion USD |
2010Q3 | 704.9 million USD | 1.9 billion USD |
2010Q2 | 712.1 million USD | 1.9 billion USD |
2010Q1 | 854.9 million USD | 2.1 billion USD |
2009Q4 | 802.2 million USD | 2.0 billion USD |
2009Q3 | 673.0 million USD | 1.8 billion USD |
2009Q2 | 569.1 million USD | 1.6 billion USD |
2009Q1 | 589.1 million USD | 1.5 billion USD |
2008Q4 | 568.2 million USD | 1.4 billion USD |
2008Q3 | 504.0 million USD | 1.4 billion USD |
2008Q2 | 442.8 million USD | 1.3 billion USD |
2008Q1 | 496.1 million USD | 1.3 billion USD |
2007Q4 | 401.6 million USD | 1.1 billion USD |
2007Q3 | 398.3 million USD | 1.1 billion USD |
2007Q2 | 407.9 million USD | 1.0 billion USD |
2007Q1 | 407.4 million USD | 1.0 billion USD |
2006Q4 | -1.7 billion USD | 899.2 million USD |
2006Q3 | -52.2 million USD | 748.7 million USD |
2006Q2 | 265.2 million USD | 685.3 million USD |
2006Q1 | 262.7 million USD | 692.9 million USD |
2005Q4 | 281.6 million USD | 609.3 million USD |
2005Q3 | 179.2 million USD | 493.5 million USD |
2005Q2 | 196.0 million USD | 495.3 million USD |
2005Q1 | 157.1 million USD | 430.4 million USD |
2004Q4 | 110.2 million USD | 369.6 million USD |
2004Q3 | 113.2 million USD | 326.2 million USD |
2004Q2 | 111.5 million USD | 319.7 million USD |
2004Q1 | 114.4 million USD | 309.1 million USD |
2003Q4 | 192.6 million USD | 263.5 million USD |
2003Q3 | 73.1 million USD | 200.4 million USD |
2003Q2 | 100.4 million USD | 238.9 million USD |
2003Q1 | -438.1 million USD | 165.1 million USD |
2002Q4 | 35.5 million USD | 145.0 million USD |
2002Q3 | 20.8 million USD | 134.0 million USD |
2002Q2 | 19.7 million USD | 109.4 million USD |
2002Q1 | -3.9 million USD | 78.4 million USD |
2001Q4 | 131.6 million USD | 74.3 million USD |
2001Q3 | -25.2 million USD | 50.9 million USD |
2001Q2 | -32.4 million USD | 50.7 million USD |
2001Q1 | -21.7 million USD | 57.8 million USD |
2000Q4 | -29.3 million USD | 55.3 million USD |
2000Q3 | -17.6 million USD | 45.1 million USD |
2000Q2 | -4.2 million USD | 50.0 million USD |
2000Q1 | -5.8 million USD | 45.2 million USD |
1999Q4 | -9.0 million USD | 48.8 million USD |
1999Q3 | -30.4 million USD | 38.4 million USD |
1999Q2 | -15.0 million USD | 8.7 million USD |
1999Q1 | -15.8 million USD | 4.9 million USD |
1998Q4 | -16.3 million USD | 9.0 million USD |
1998Q3 | -17.6 million USD | 3.0 million USD |
1998Q2 | -14.8 million USD | 7.0 million USD |
1998Q1 | -7.4 million USD | 13.6 million USD |
1997Q4 | -12.4 million USD | 9.9 million USD |
1997Q3 | -10.3 million USD | 4.9 million USD |
1997Q2 | 2.7 million USD | 19.7 million USD |
1997Q1 | -7.9 million USD | 5.5 million USD |
1996Q4 | -8.0 million USD | 5.8 million USD |
1996Q3 | 9.3 million USD | 24.7 million USD |
1996Q2 | -12.2 million USD | 2.2 million USD |
1996Q1 | -10.8 million USD | 800000 USD |
1995Q3 | -8.4 million USD | 1.1 million USD |
1995Q2 | -7.9 million USD | 900000 USD |
1995Q1 | -8.9 million USD | 900000 USD |
1994Q4 | -8.2 million USD | 1.3 million USD |
1994Q3 | -7.0 million USD | 1.6 million USD |
1994Q2 | -7.2 million USD | 1.1 million USD |
1994Q1 | -8.4 million USD | 1.1 million USD |
1993Q4 | -6.7 million USD | 1.1 million USD |
1993Q3 | -5.8 million USD | 1.0 million USD |
1993Q2 | -4.8 million USD | 1.0 million USD |
1993Q1 | -5.7 million USD | 1.0 million USD |
1992Q4 | -3.9 million USD | 1.0 million USD |
1992Q3 | -2.7 million USD | 1.0 million USD |
1992Q2 | -1.8 million USD | 1.1 million USD |
1992Q1 | ? USD | 1.9 million USD |
1991Q4 | ? USD | 500000 USD |
1991Q3 | ? USD | 200000 USD |
1991Q2 | ? USD | 200000 USD |
1991Q1 | -1.0 million USD | 1.2 million USD |
1990Q4 | -900000 USD | 100000 USD |
1990Q3 | -1.0 million USD | 100000 USD |
1990Q2 | -1.0 million USD | 100000 USD |
GILD Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 5.7 billion USD | 27.1 billion USD |
2022 | 4.6 billion USD | 27.3 billion USD |
2021 | 6.2 billion USD | 27.3 billion USD |
2020 | 89.0 million USD | 24.7 billion USD |
2019 | 5.4 billion USD | 22.4 billion USD |
2018 | 5.5 billion USD | 22.1 billion USD |
2017 | 4.6 billion USD | 26.1 billion USD |
2016 | 13.5 billion USD | 30.4 billion USD |
2015 | 18.1 billion USD | 32.6 billion USD |
2014 | 12.1 billion USD | 24.9 billion USD |
2013 | 3.1 billion USD | 11.2 billion USD |
2012 | 2.6 billion USD | 9.7 billion USD |
2011 | 2.8 billion USD | 8.4 billion USD |
2010 | 2.9 billion USD | 7.9 billion USD |
2009 | 2.6 billion USD | 7.0 billion USD |
2008 | 2.0 billion USD | 5.3 billion USD |
2007 | 1.6 billion USD | 4.2 billion USD |
2006 | -1.2 billion USD | 3.0 billion USD |
2005 | 813.9 million USD | 2.0 billion USD |
2004 | 449.4 million USD | 1.3 billion USD |
2003 | -72.0 million USD | 867.9 million USD |
2002 | 72.1 million USD | 466.8 million USD |
2001 | 52.3 million USD | 233.8 million USD |
2000 | -56.8 million USD | 195.6 million USD |
1999 | -66.5 million USD | 169.0 million USD |
1998 | -56.1 million USD | 32.6 million USD |
1997 | -28.0 million USD | 40.0 million USD |
1996 | -21.7 million USD | 33.4 million USD |
1995 | -27.4 million USD | 2.7 million USD |
1994 | -31.3 million USD | 4.9 million USD |
1993 | -25.7 million USD | 4.1 million USD |
1992 | -14.1 million USD | 4.2 million USD |
1991 | -4.5 million USD | 2.8 million USD |
1990 | -4.0 million USD | 1.3 million USD |
GILD
List: Challengers
Price: 73.44USD
Dividend Yield: 4.22%
Forward Dividend Yield: 4.22%
Payout Ratio: 65.12%
Dividend Per Share: 3.08 USD
Earnings Per Share: 4.73 USD
P/E Ratio: 15.59
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.7 million
Ebitda: 2.4 billionMarket Capitalization: 91.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 10
DGR3: 3.21%
DGR5: 5.30%